Our team has over a hundred years of combined experience, managing portfolios through five economic cycles.
Board of Directors
Philippe Audi
Philippe has more than 20 years of experience in private banking and private equity. He is a founding partner of Levant Capital and is currently a member of the Board of Directors of Bayara (UAE), Panço (Turkey), Papa John’s Pizza (UAE), and Al-Raya Supermarkets (Saudi Arabia). Philippe worked at Merrill Lynch in New York and has an MBA from the Wharton School.
Salameh Sweis
Salameh has more than 20 years of experience in private equity and finance. He is a founding partner of Levant Capital and its CEO. Salameh is currently a member of the Board of Directors of Bayara (UAE), Power Horse (Austria), Panço (Turkey), Papa John’s Pizza (UAE), and Al-Raya Supermarkets (Saudi Arabia). Salameh worked at Goldman Sachs in New York and has a BS from Rensselaer Polytechnic Institute.
Marios Fotiadis
Marios has more than 20 years of experience in venture capital and private equity in the healthcare and life sciences sectors. He is currently a member of the Board of Directors of IRRAS (Sweden), Senté (US), Klaris SA (Luxembourg), and Opocrin SpA (Italy). He has worked at TVM Capital, Advent International, and SG Capital Partners. Marios has an MBA from Columbia University.
Team
Yves Gloor
(Geneva - Stork Capital)
Yves manages operations in Geneva. He has more than 25 years of experience in private banking with Lombard Odier and the family office Sun Partners. Yves has worked in Geneva, Hong Kong and New York.
Caroline Hooft Graafland
(Dubai - Levant Capital)
Caroline has more than 5 years of experience in wealth management with Stonehage Fleming and Schroders in London.
Life Sciences
Kleanthis Xanthopoulos
(La Jolla, California - Chairman Stork Capital Life Sciences)
Kleanthis G. Xanthopoulos, Ph.D. has more than 23 years of experience as a serial entrepreneur in life sciences. He is currently President & CEO of IRRAS AB (NASDAQ: IRRAS). Prior to that he was the founding President & CEO of Regulus Therapeutics Inc. (NASDAQ: RGLS). Kleanthis also co-founded and served as President & CEO of Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) until its acquisition by Roche. He received a B.Sc. in Biology with honors from Aristotle University of Thessaloniki, Greece, and an M.Sc. in Microbiology and Ph.D. in Molecular Biology from the University of Stockholm, Sweden. He is an Onassis Scholar and was an Associate Professor at the Karolinska Institute, Sweden. He has been recognized as E&Y Entrepreneur of the Year, 2006, and Most Admired CEO, for medium-sized public company in 2013 in San Diego.
Simon Fricker, CFA, CAIA
(Geneva - Stork Capital)
Simon co-heads portfolio management and has 30 years of experience as an investment specialist with UBS, Bank Leu, Banque Edmond de Rothschild, BNP Paribas and KBL.